Fingerprint
Dive into the research topics where Figen Cakiroglu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 9 Journal articles
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
DUPRO steering committee and PROTECT Investigators, 02.12.2023, In: The Lancet. 402, 10417, p. 2077-2090 14 p.Research output: Journal Articles › Journal articles › Research › peer-review
215 Link opens in a new tab Citations (Scopus)